secwatch.observer — SEC 8-K summary
======================================

Issuer:     GENELUX Corp (GNLX)
CIK:        0001231457
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001493152-25-004554
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genelux CFO Lourie Zak resigns; Matt Pulisic appointed CFO with $410k salary, 275k option
--------------------------------------------------------------------------------

- Lourie Zak resigned as CFO effective Jan 29, 2025; separation includes $180k cash payment (6 months salary) and advisory role through Aug 29, 2025.
- Matt Pulisic appointed CFO effective Jan 30, 2025; previously VP Finance at Arrowhead Pharmaceuticals.
- Pulisic receives base salary of $410,000/year, target bonus of 40% of base, and option to purchase 275,000 shares at $3.95/share.
- Option vests over 4 years (25% after one year, then monthly); full acceleration upon change in control.
- Pulisic eligible for severance: 6 months base salary without cause, 12 months base salary if termination within change in control period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer